HHLR Advisors, Ltd., 10% Owner at ArriVent Biopharma, Inc. (AVBP), bought 868,631 shares at $18.00 ($10.0M) on 2024-01-30, disclosed to the SEC on 2024-02-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 313,076 | $0 | 0.0% |
| 2 | $18.00 | 555,555 | $10.0M | 100.0% |
| Total | $11.51 avg | 868,631 | $10.0M | 100% |
| Filing → |